Credit: Shutterstock
As the XBI suffers, Q1 shows a few comforting signs of underlying stability
The XBI has plunged 27% since Donald Trump won the election, leaving the public markets an ugly mess for a biotech industry yearning for better …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
